criptococică şi imunosupresie.
Profilaxia secundară a candidozei orofaringiene la
pacienţi cu imunosupresie.
Tratamentul meningitei criptococice la pacienţii care
nu pot lua sau nu tolerează amfotericina.
Tratamentul candidozelor severe şi care pun în pericol
viaţa la pacienţi care nu tolerează amfotericina.
Tratamentul candidozei orofaringiene la pacienţi cu
imunosupresie.
Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului.
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
J02AC01 FLUCONAZOLUM CAPS. 100 mg
DIFLAZON 100 mg 100 mg KRKA D.D.
FLUCONAZOLE TEVA 100 mg 100 mg TEVA PHARMACEUTICALS SRL
FLUCORIC 100 mg 100 mg TERAPIA S.A.
FLUCOVIM 100 100 mg VIM SPECTRUM SRL
FUNGOLON 100 mg 100 mg BALKANPHARMA RAZGRAD AD
J02AC01 FLUCONAZOLUM CAPS. 150 mg
DIFLAZON 150 mg 150 mg KRKA D.D.
DIFLUCAN 150 mg 150 mg PFIZER EUROPE MA EEIG
FLUCONAZOL 150 mg 150 mg OZONE LABORATORIES LTD.
FLUCONAZOL MEDICO UNO 150 mg 150 mg MEDICO UNO PHARMACEUTICAL
SRL
FLUCONAZOL MEDOCHEMIE 150 mg 150 mg MEDOCHEMIE ROMANIA SRL
FLUCONAZOL SANDOZ(R) 150 150 mg SANDOZ SRL
FLUCONAZOL TERAPIA 150 mg 150 mg TERAPIA SA
FLUCONAZOLE TEVA 150 mg 150 mg TEVA PHARMACEUTICALS SRL
FLUCORIC 150 mg 150 mg TERAPIA S.A.
FLUCOVIM 150 150 mg VIM SPECTRUM SRL
MYCOMAX 150 150 mg ZENTIVA AS
MYCOSYSTA(R) 150 mg 150 mg GEDEON RICHTER PLC.
J02AC01 FLUCONAZOLUM CAPS. 200 mg
DIFLAZON 200 mg 200 mg KRKA D.D.
FLUCONAZOLE TEVA 200 mg 200 mg TEVA PHARMACEUTICALS SRL
J02AC01 FLUCONAZOLUM SOL. PERF. 2 mg/ml
DIFLAZON(R) 2 mg/ml KRKA D.D.
DIFLUCAN(R) 2 mg/ml PFIZER EUROPE MA EEIG
MYCOMAX(R) INF 2 mg/ml ZENTIVA AS
J02AC01 FLUCONAZOLUM CAPS. 50 mg
DIFLAZON 50 mg 50 mg KRKA D.D.
DIFLUCAN 50 mg 50 mg PFIZER EUROPE MA EEIG
FLUCONAZOL 50 mg 50 mg ARENA GROUP SA
FLUCONAZOL MEDOCHEMIE 50 mg 50 mg MEDOCHEMIE ROMANIA SRL
FLUCONAZOL SANDOZ(R) 50 50 mg SANDOZ SRL
FLUCONAZOL TERAPIA 50 mg 50 mg TERAPIA S.A.
FLUCONAZOLE TEVA 50 mg 50 mg TEVA PHARMACEUTICALS SRL
FLUCORIC 50 mg 50 mg TERAPIA S.A.
FLUCOVIM 50 50 mg VIM SPECTRUM SRL
FUNGOLON 50 mg 50 mg BALKANPHARMA RAZGRAD AD
J02AC01 FLUCONAZOLUM PULB. PT. SUSP. ORALA 50 mg/5 ml
DIFLUCAN(R) 50 mg/5 ml 50 mg/5 ml PFIZER EUROPE MA EEIG
________________________________________________________________________________
______________________________________________________________________________
| 930 |J02AC03| VORICONAZOLUM** | Protocol: J012B |
|_______|_______|____________________________________________|_________________|
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
J02AC03 VORICONAZOLUM COMPR. FILM. 200 mg
VFEND 200 mg 200 mg PFIZER LTD.
J02AC03 VORICONAZOLUM PULB. PT. SOL. PERF. 200 mg
VFEND 200 mg 200 mg PFIZER LTD.
J02AC03 VORICONAZOLUM PULB. PT. SUSP. ORALA 40 mg/ml
VFEND 40 mg/ml 40 mg/ml PFIZER LTD.
J02AC03 VORICONAZOLUM COMPR. FILM. 50 mg
VFEND 50 mg 50 mg PFIZER LTD.
________________________________________________________________________________
______________________________________________________________________________
| 932 |J05AB14| VALGANCICLOVIRUM** | |
|_______|_______|____________________________________________|_________________|
Prescriere limitată: Tratamentul de iniţiere şi menţinere pentru retinita cu citomegalovirus (CMV) la pacienţi imunocompromişi.
________________________________________________________________________________
DCI/DENUMIRE COMERCIALĂ FORMA FARM.
__________________________________________________
CONCENTRAŢIE FIRMA
________________________________________________________________________________
J05AB14 VALGANCICLOVIRUM COMPR. FILM. 450 mg
VALCYTE(R) 450 mg 450 mg ROCHE ROMANIA SRL
________________________________________________________________________________
______________________________________________________________________________
| 933 |L04AA01| CICLOSPORINUM | |
|_______|_______|____________________________________________|_________________|
Prescriere limitată: Managementul rejectului de grefa la pacienţii supuşi procedurii de transplant.
Monitorizarea atentă a pacienţilor este obligatorie.
Dostları ilə paylaş: |